Zdrowie i gospodarka · 11/08/2014

FDA Seeks Public Comment on Blood Establishment Registration and Product Listing Requirements

The Food and Drug Administration (FDA) is seeking public comment on its proposed collection of information related to blood establishment registration and product listing requirements. The agency must publish this notice in the Federal Register and allow 60 days for public feedback.